Two human hepatoma cell lines, HepG2 and Huh-7 with high expression levels of FZD7 were selected to test the efficacy of Fz7-21 as an antagonist of Wnt/β-catenin signaling. The gene discussed is FZD7; the disease is hepatocellular carcinoma.